Is this your brand? Sign in to claim ownership.
Sign in to claim this brandETABLISSEMENTS ANTHOGYR
US
Last updated May 24, 2026
What ETABLISSEMENTS ANTHOGYR makes
The company manufactures reusable and single-use dental implant suprastructures, including temporary and permanent preformed types, as well as dental implant abutment analogs designed for laboratory use. Their portfolio also includes reusable dental drill bits, surgical screwdrivers, depth limiters for implants, and reusable bone taps, all tailored for dental and surgical procedures.
These devices are classified under FDA regulations as Class I and Class II, with listings maintained in the FDA’s Unique Device Identifier (UDI) database. The company operates from the United States, adhering to applicable regulatory standards for medical devices in that jurisdiction.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Etablissements Anthogyr manufacture?
Etablissements Anthogyr specializes in dental and surgical devices. Their portfolio includes reusable and single-use dental implant suprastructures (both temporary and permanent preformed types), dental implant abutment analogs for laboratory use, dental drill bits, surgical screwdrivers, depth limiters for implants, and reusable bone taps. These devices are designed for precision in dental and surgical procedures.
Where is Etablissements Anthogyr based?
Etablissements Anthogyr is based in the United States. The company operates within this jurisdiction, ensuring its devices comply with applicable U.S. regulatory standards for medical devices.
Which regulatory registries list Etablissements Anthogyr’s devices?
Etablissements Anthogyr’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify their products under FDA regulations, ensuring transparency and traceability for authorized devices.
How are Etablissements Anthogyr’s devices classified under FDA regulations?
Etablissements Anthogyr’s devices fall under two FDA classification categories: Class I and Class II. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve a higher level of risk and may require special controls to ensure safety and effectiveness. The classification depends on the specific device type and its intended use.
What distinguishes Etablissements Anthogyr’s dental implant suprastructures from other similar devices?
Etablissements Anthogyr offers both reusable and single-use dental implant suprastructures, including temporary and permanent preformed types. The distinction lies in their design for specific procedural needs—temporary suprastructures may be used for interim support, while permanent ones provide long-term stability. The company’s portfolio also includes reusable alternatives, catering to practices prioritizing cost efficiency and sustainability.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- anthogyr.com
- —
- —
- [email protected]
- Phone
- +33450584888
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 275978864
Catalogue (274)
Page 4 of 6| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Axiom® | INKITSSBL | FDA UDI | Class I | Active |
| Axiom® | OPFI20S | FDA UDI | Class I | Active |
| Axiom® | 10430 | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | OPGPDM | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | OPFF45 | FDA UDI | Class I | Active |
| Axiom® | GCBG42S | FDA UDI | Class I | Active |
| Axiom® | GFI20L8G36 | FDA UDI | Class I | Active |
| Axiom® | OPCR404 | FDA UDI | Class I | Active |
| Axiom® | OPB3608L | FDA UDI | Class I | Active |
| Axiom® | OPB4806C | FDA UDI | Class I | Active |
| Axiom® | OPAF041 | FDA UDI | Class I | Active |
| Impulsion | 87M | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | OPGS20-4 | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | OPPU100L-4 | FDA UDI | Class I | Active |
| Axiom® | OPR8 | FDA UDI | Class I | Active |
| Axiom® | MUA100 | FDA UDI | Class I | Active |
| Axiom® | MUAA142-4 | FDA UDI | Class I | Active |
| Axiom® | MUM100L | FDA UDI | Class I | Active |
| Axiom® | OPGDM-20S | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | MUNT200 | FDA UDI | Class I | Active |
| Axiom® | GFI20L6G50 | FDA UDI | Class I | Active |
| Axiom® | OPFLEX523-ET | FDA UDI | Class II | Active |
| Axiom® | OPCA504 | FDA UDI | Class I | Active |
| Axiom® | GTA34G50S | FDA UDI | Class I | Active |
| Axiom® | 10420 | EUDAMEDFDA UDI | Class I | Active |
| Axiom® | PA-TOOL-01CAP | FDA UDI | Class I | Active |
| Axiom® | GTA46G50S | FDA UDI | Class I | Active |
| Axiom | OPACR23 | FDA UDI | Class II | Active |
| Axiom | OP40180 | FDA UDI | Class II | Active |
| Axiom® | OPB3010C | FDA UDI | Class I | Active |
| Axiom® | GFE42L12G50 | FDA UDI | Class I | Active |
| Axiom | OPSC020 | FDA UDI | Class II | Active |
| Axiom® | CR25-4 | FDA UDI | Class I | Active |
| Axiom® | GFI20L14G42 | FDA UDI | Class I | Active |
| Axiom® | GFE24L12G50 | FDA UDI | Class I | Active |
| Axiom | OPST416-23 | FDA UDI | Class II | Active |
| Axiom | OPSC400 | FDA UDI | Class II | Active |
| Axiom® | OPB4808C | FDA UDI | Class I | Active |
| Axiom® | 10475 | FDA UDI | Class I | Active |
| Axiom | OPAC300 | FDA UDI | Class II | Active |
| Axiom | OPAC043 | FDA UDI | Class II | Active |
| Axiom® | MUFLEX-ET | FDA UDI | Class II | Active |
| Axiom® | OPFI15S | FDA UDI | Class I | Active |
| Axiom® | OPGS36 | FDA UDI | Class I | Active |
| Axiom® | MUA200-4 | FDA UDI | Class I | Active |
| Axiom® | MUNFLEX | FDA UDI | Class II | Active |
| Axiom® | OPB3608C | FDA UDI | Class I | Active |
| Axiom® | INMHECV | FDA UDI | Class I | Active |
| Axiom® | OPFES-6 | FDA UDI | Class I | Active |
| Axiom® | INMODOPS3 | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.